Fundamental Analysis of KRONOS BIO INC(NASDAQ:KRON) stock

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to KRON. KRON was compared to 588 industry peers in the Biotechnology industry. KRON has a great financial health rating, but its profitability evaluates not so good. KRON is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year KRON has reported negative net income.

KRON had a negative operating cash flow in the past year.

KRON had negative earnings in each of the past 5 years.

In the past 5 years KRON always reported negative operating cash flow.

1.2 Ratios

KRON has a Return On Assets (-52.83%) which is in line with its industry peers.

KRON has a Return On Equity (-70.83%) which is in line with its industry peers.

		Industry Rank	Sector Rank
ROA	-52.83%
ROE	-70.83%
ROIC	N/A

ROA(3y)-45.53%

ROA(5y)-33.91%

ROE(3y)-56.36%

ROE(5y)-40.85%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KRON so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

KRON does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, KRON has more shares outstanding

KRON has more shares outstanding than it did 5 years ago.

KRON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

KRON has an Altman-Z score of -3.60. This is a bad value and indicates that KRON is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -3.60, KRON perfoms like the industry average, outperforming 42.29% of the companies in the same industry.

KRON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-3.6

ROIC/WACCN/A

WACC9.29%

2.3 Liquidity

KRON has a Current Ratio of 7.24. This indicates that KRON is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 7.24, KRON is in the better half of the industry, outperforming 69.69% of the companies in the same industry.

A Quick Ratio of 7.24 indicates that KRON has no problem at all paying its short term obligations.

With a decent Quick ratio value of 7.24, KRON is doing good in the industry, outperforming 69.69% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	7.24
Quick Ratio	7.24

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

KRON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.52%, which is quite impressive.

EPS 1Y (TTM)21.52%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q39.29%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Revenue growth Q2QN/A

3.2 Future

KRON is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.15% yearly.

KRON is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 147.67% yearly.

EPS Next Y15.73%

EPS Next 2Y2.71%

EPS Next 3Y1.15%

EPS Next 5YN/A

Revenue Next Year7.97%

Revenue Next 2Y-23.07%

Revenue Next 3Y-25.99%

Revenue Next 5Y147.67%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

KRON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year KRON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y2.71%

EPS Next 3Y1.15%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for KRON!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KRONOS BIO INC

NASDAQ:KRON (4/26/2024, 12:13:43 PM)

0.9975

+0.02 (+1.79%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap59.95M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-52.83%
ROE	-70.83%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.03

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	7.24
Quick Ratio	7.24
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)21.52%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y15.73%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

KRONOS BIO INC (KRON)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens